3rd Annual Symposium on Individualized Novel Disease-Modifying Treatment Options for Multiple Sclerosis

For more information visit: www.mednetus.net

Teva Pharmaceuticals
Genzyme Corporation

Specialty: Multiple Sclerosis

These webcasts are intended to provide paradigm shift in the treatment options for multiple sclerosis. The format will include didactic lectures from known thought leaders, question and answer sessions, case report presentation and ample opportunity for participant interaction with faculty. These enduring online activities are designed to provide clinical decision-making strategies for integration of novel therapeutic options.

This series consists of 3 continuing education webcasts.